Weifei Fan

594 total citations
25 papers, 434 citations indexed

About

Weifei Fan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weifei Fan has authored 25 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Weifei Fan's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Weifei Fan is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Weifei Fan collaborates with scholars based in China and United States. Weifei Fan's co-authors include Yuan Mao, Louqian Zhang, Shuihong Yao, Hongyu Shen, Chun Lu, Lin Xiong, Suyao Liu, Lin Xu, Qin Yan and Li Wan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Gene.

In The Last Decade

Weifei Fan

23 papers receiving 433 citations

Peers

Weifei Fan
Zhongping Tang China
Minghui Zhang China
Shuier Zheng China
Yanjun Gu China
Vera Kloten Germany
María Villa‐Morales Spain
Xiaojian Ni China
Yanmei Cui China
Wenzheng Yuan China
Yongfeng Wu China
Zhongping Tang China
Weifei Fan
Citations per year, relative to Weifei Fan Weifei Fan (= 1×) peers Zhongping Tang

Countries citing papers authored by Weifei Fan

Since Specialization
Citations

This map shows the geographic impact of Weifei Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifei Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifei Fan more than expected).

Fields of papers citing papers by Weifei Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifei Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifei Fan. The network helps show where Weifei Fan may publish in the future.

Co-authorship network of co-authors of Weifei Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Weifei Fan. A scholar is included among the top collaborators of Weifei Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifei Fan. Weifei Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Xiao Yan, Yue Gao, Jiajia Lv, Weifei Fan, & Lin Wang. (2025). Vascular mimicry developments in non-small cell lung cancer. Biochemical and Biophysical Research Communications. 776. 152195–152195.
2.
Chen, Haiming, et al.. (2024). Plasma cell-free DNA as a sensitive biomarker for multi-cancer detection and immunotherapy outcomes prediction. Journal of Cancer Research and Clinical Oncology. 150(1). 7–7. 4 indexed citations
3.
4.
Shen, Hongyu, et al.. (2021). Hsa_circ_0001361 facilitates the progress of lung adenocarcinoma cells via targeting miR-525-5p/VMA21 axis. Journal of Translational Medicine. 19(1). 389–389. 14 indexed citations
5.
Yao, Shuihong, Xuemei Jia, Fei Wang, et al.. (2021). CircRNA ARFGEF1 functions as a ceRNA to promote oncogenic KSHV-encoded viral interferon regulatory factor induction of cell invasion and angiogenesis by upregulating glutaredoxin 3. PLoS Pathogens. 17(2). e1009294–e1009294. 23 indexed citations
6.
7.
Yang, Shu, Xuefeng Gu, Hongyu Shen, et al.. (2019). SPARC correlates with unfavorable outcome and promotes tumor growth in lung squamous cell carcinoma. Experimental and Molecular Pathology. 110. 104276–104276. 11 indexed citations
8.
Mao, Yuan, Li Xu, Jun Wang, et al.. (2019). ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway. BioFactors. 45(3). 416–426. 27 indexed citations
9.
Mao, Yuan, Weifei Fan, Hao Hu, et al.. (2019). MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells. Journal of Hematology & Oncology. 12(1). 106–106. 47 indexed citations
10.
Wang, Lin, Suyao Liu, Yuan Mao, et al.. (2018). CircRNF13 regulates the invasion and metastasis in lung adenocarcinoma by targeting miR-93-5p. Gene. 671. 170–177. 29 indexed citations
11.
Wang, Jun, Wei Li, Weifei Fan, et al.. (2018). COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells. Biomedicine & Pharmacotherapy. 103. 373–380. 31 indexed citations
12.
Yao, Shuihong, Jingyun Xu, Qin Yan, et al.. (2018). Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways. Cell Death and Disease. 9(11). 1055–1055. 54 indexed citations
13.
Hou, Nan, Xiaohua Chen, Zhiping Xu, et al.. (2017). High expression of NDRG3 associates with unfavorable overall survival in non-small cell lung cancer. Cancer Biomarkers. 21(2). 461–469. 15 indexed citations
14.
Ma, Jun, Jun Wang, Weifei Fan, et al.. (2014). Upregulated TIMP-1 correlates with poor prognosis of laryngeal squamous cell carcinoma.. PubMed. 7(1). 246–54. 27 indexed citations
15.
Yang, Ju, Yajing Weng, Weifei Fan, et al.. (2014). High SHIP2 Expression Indicates Poor Survival in Colorectal Cancer. Disease Markers. 2014. 1–7. 20 indexed citations
16.
Fan, Weifei, Wei Zhang, Feng Chang, et al.. (2013). Elevated expression of SHIP2 correlates with poor prognosis in non-small cell lung cancer.. PubMed. 6(10). 2185–91. 32 indexed citations
17.
Wang, Lin, Jie Shen, Lijuan Meng, et al.. (2013). [Correlation between the methylation of SULF2 and WRN promoter and chemosensitivity to irinotecan in gastric cancer].. PubMed. 35(6). 418–22. 1 indexed citations
18.
Meng, Lijuan, et al.. (2011). Evaluation of oral chemotherapy with capecitabine and cyclophosphamide plus thalidomide and prednisone in prostate cancer patients. Journal of Cancer Research and Clinical Oncology. 138(2). 333–339. 15 indexed citations
19.
Wang, Jun, et al.. (2011). [Risk factors and prognosis of lung cancer combined with pulmonary embolism].. SHILAP Revista de lepidopterología. 14(10). 780–4. 6 indexed citations
20.
Fan, Weifei. (2008). Analysis of feasibility of lung cancer screening with low-radiation-dose spiral CT scan plus detection of p16 gene methylation in serum. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhongping Tang Breakdown of academic impact, for papers by Minghui Zhang Breakdown of academic impact, for papers by Shuier Zheng Breakdown of academic impact, for papers by Yanjun Gu Breakdown of academic impact, for papers by Vera Kloten Breakdown of academic impact, for papers by María Villa‐Morales Breakdown of academic impact, for papers by Xiaojian Ni Breakdown of academic impact, for papers by Yanmei Cui Breakdown of academic impact, for papers by Wenzheng Yuan Breakdown of academic impact, for papers by Yongfeng Wu
Rankless by CCL
2026